呼吸器疾患検査のアメリカ市場2017-2021

Venture Planning Groupが発行した調査報告書(DATA70209041)
◆英語タイトル:2017-2021 US Respiratory Diseases Diagnostic Testing Market
◆商品コード:DATA70209041
◆発行会社(リサーチ会社):Venture Planning Group
◆発行日:2017年2月7日
◆ページ数:283
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療
◆販売価格オプション(消費税別)
Local PDF(同一事業所内共有可)USD3,600 ⇒換算¥406,800見積依頼/購入/質問フォーム
Global PDF(全事業所で共有可)USD7,900 ⇒換算¥892,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はVenture Planning Group社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Venture Planning Group社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

About This Report

This new 283-page report from VPGMarketResearch.com presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs.

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

-  Reviews features and operating characteristics of major analyzers used 
   for microbiology testing;

-  Profiles key suppliers and potential market entrants developing innovative
   technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies, 
   market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.

Contains 283 pages and 23 tables


About This Report

This new 283-page report from VPGMarketResearch.com presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs.

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

-  Reviews features and operating characteristics of major analyzers used 
   for microbiology testing;

-  Profiles key suppliers and potential market entrants developing innovative
   technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies, 
   market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.
 
Contains 283  pages and 23  tables



【レポートの目次】

http://www.vpgcorp.com/webfiles/INFECTIOUSDISEASEPDF/TOC-TOTUSRespiratoryDiseasesGlobalMarketOutlookandEmergingOpportunities.pdf

http://www.vpgmarketresearch.com/pdffiles/LOTUSRespiratoryDiseasesGlobalMarketOutlookandEmergingOpportunities.pdf

【レポートのキーワード】

呼吸器疾患検査

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 呼吸器疾患検査のアメリカ市場2017-2021(2017-2021 US Respiratory Diseases Diagnostic Testing Market )]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆